Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Pharmacokinetic Study and Incurred Sample Stability of Esomeprazole in Dried Blood Spot Sample Using High Performance Liquid Chromatography-Photodiode Array

Indonesian Journal of Chemistry · Vol. 20 No. 5 (2020) · hlm. 979–979

DOI
10.22146/ijc.42404
ISSN
1411-9420, 2460-1578
Terbit
2020-07-18
Penerbit
Gadjah Mada University
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc-nd/4.0/

Abstrak

In the past years, Esomeprazole (EMP) was analyzed in human plasma samples, which still has stability issues; thus, the new biosampling technique known as Dried Blood Spot (DBS) might solve the issue. This research aims to evaluate the incurred sample stability of esomeprazole in dried blood spot using high performance liquid chromatography-photodiode array with lansoprazole as an internal standard. The analytical separation was performed on a C-18 column (Waters, Sunfire™ 5 μm; 250 × 4.6 mm) at 40 °C. The mobile phase used was acetonitrile–phosphate buffer pH 7.6 (40:60% v/v) with a flow rate of 1.00 mL/min; and was detected at 300 nm. The analyte was extracted from dried blood spot by methanol. Incurred sample stability was evaluated from 6 healthy subjects on day 0, 7, 14, and 28, respectively. This method was linear in the range concentration of 70–1400 ng/mL with r > 0.98. Pharmacokinetic study shows that the average of AUC0–t of EMP in the DBS sample was 1765.41 ngh/mL. The highest percent difference value of esomeprazole’s incurred samples stability on day 7, 14, and 28 from 6 healthy subjects were 9.81%. This result fulfilled the acceptance criteria, which is the percent difference should not be greater than 20%, and 67% of total samples have to fulfill the criteria. The incurred sample stability result showed that esomeprazole was stable in the DBS sample at least until 28 days with the highest value of percent difference is 9.81%.

Kata kunci

Jaringan kolaborasi para penulis

38 penulis · 111 tautan kepenulisan bersama · 48 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Indonesia
  • Diponegoro University
  • Indonesia Defense University
  • National Nuclear Energy Agency of Indonesia
  • National Research and Innovation Agency
  • Sunan Kalijaga State Islamic University Yogyakarta
  • Padjadjaran University
  • Organisasi lain
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Faonaso HarefaIndonesia Defense University2
Dian Andriani Ratna DewiIndonesia Defense University2
Sutanto SutantoIndonesia Defense University2
Revina Intan PraditaSunan Kalijaga State Islamic University Yogyakarta1
Lila Irawati Tjahjo WiduriIndonesia Defense University1
Abdul MutalibPadjadjaran University1
Sandra HermantoSyarif Hidayatullah State Islamic University Jakarta1
Sunarhadijoso SoenarjoNational Nuclear Energy Agency of Indonesia1
Ratna Dini HaryuniNational Nuclear Energy Agency of Indonesia1
Anton BahtiarUniversity of Indonesia1
Martalena RamliNational Nuclear Energy Agency of Indonesia1
C.N. ArdiyatnoNational Nuclear Energy Agency of Indonesia1
Veronika Yulianti SusiloNational Nuclear Energy Agency of Indonesia1
D. HaffidNational Nuclear Energy Agency of Indonesia1
Redemtus Heru TjahjanaDiponegoro University1
Sutimin SutiminDiponegoro University1
Ocha Putri MuliaUniversity of Indonesia1
Febri LS LarosaUniversity of Indonesia1
Tri Hastuti SeptiariniUniversity of Indonesia1
Ratika RahmasariUniversity of Indonesia1
Ervia YudiatiDiponegoro University1
Sri SejatiDiponegoro University1
Rani AgustianDiponegoro University1
Enny Rimita SembiringNational Research and Innovation Agency1
Asrul Muhammad FuadNational Research and Innovation Agency1
Jusman RahimDiponegoro University1
Lilin BudiatiDiponegoro University1
Supandi SupandiUniversitas Muhammadiyah Prof Dr Hamka1
Harmita HarmitaUniversity of Indonesia1
Rizka AndalusiaDharmais Cancer Hospital1
Cecilia F. HarsonoIndonesia Defense University1
R.M. Tjahya NurrobiIndonesia Defense University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764840418, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Pharmacokinetic Study and Incurred Sample Stability of Esomeprazole in Dried Blood Spot Sample Using High Performance Liquid Chromatography-Photodiode Array</dc:title><dc:creator>Yahdiana Harahap</dc:creator><dc:creator>Anja Tamabri</dc:creator><dc:creator>Vicha Vicha</dc:creator><dc:creator>Herman Suryadi</dc:creator><dc:creator>Sunarsih Sunarsih</dc:creator><dc:creator>Callista Andinie Mulyadi</dc:creator><dc:subject>esomeprazole</dc:subject><dc:subject>dried blood spots</dc:subject><dc:subject>pharmacokinetics</dc:subject><dc:subject>sample storage stability</dc:subject><dc:subject>H2 receptor antagonists</dc:subject><dc:description xml:lang="en">In the past years, Esomeprazole (EMP) was analyzed in human plasma samples, which still has stability issues; thus, the new biosampling technique known as Dried Blood Spot (DBS) might solve the issue. This research aims to evaluate the incurred sample stability of esomeprazole in dried blood spot using high performance liquid chromatography-photodiode array with lansoprazole as an internal standard. The analytical separation was performed on a C-18 column (Waters, Sunfire™ 5 μm; 250 × 4.6 mm) at 40 °C. The mobile phase used was acetonitrile–phosphate buffer pH 7.6 (40:60% v/v) with a flow rate of 1.00 mL/min; and was detected at 300 nm. The analyte was extracted from dried blood spot by methanol. Incurred sample stability was evaluated from 6 healthy subjects on day 0, 7, 14, and 28, respectively. This method was linear in the range concentration of 70–1400 ng/mL with r &gt; 0.98. Pharmacokinetic study shows that the average of AUC0–t of EMP in the DBS sample was 1765.41 ngh/mL. The highest percent difference value of esomeprazole’s incurred samples stability on day 7, 14, and 28 from 6 healthy subjects were 9.81%. This result fulfilled the acceptance criteria, which is the percent difference should not be greater than 20%, and 67% of total samples have to fulfill the criteria. The incurred sample stability result showed that esomeprazole was stable in the DBS sample at least until 28 days with the highest value of percent difference is 9.81%.</dc:description><dc:publisher>Gadjah Mada University</dc:publisher><dc:date>2020-07-18</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.22146/ijc.42404</dc:identifier><dc:identifier>10.22146/ijc.42404</dc:identifier><dc:source>Indonesian Journal of Chemistry; Vol 20 No 5 (2020); 979-979</dc:source><dc:source>1411-9420</dc:source><dc:source>2460-1578</dc:source><dc:language>en</dc:language><dc:relation>https://jurnal.ugm.ac.id/ijc/article/download/42404/25948</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights></oai_dc:dc>